|
|
Volumn 155, Issue 1, 1998, Pages 152-155
|
|
Olanzapine on trial (multiple letters)
a a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HALOPERIDOL;
OLANZAPINE;
BENZODIAZEPINE DERIVATIVE;
DRUG DERIVATIVE;
NEUROLEPTIC AGENT;
PIRENZEPINE;
COMORBIDITY;
LETTER;
MENTAL DISEASE;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SUBSTANCE ABUSE;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
HUMAN;
METHODOLOGY;
MULTICENTER STUDY;
NOTE;
PATIENT SELECTION;
STANDARD;
ADVERTIZING;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
PUBLICATION;
SINGLE BLIND PROCEDURE;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CONTROLLED CLINICAL TRIALS;
DOUBLE-BLIND METHOD;
HUMANS;
MULTICENTER STUDIES;
PATIENT SELECTION;
PIRENZEPINE;
RESEARCH DESIGN;
SCHIZOPHRENIA;
ADVERTISING;
DRUG INDUSTRY;
FINANCIAL SUPPORT;
PERIODICALS;
SINGLE-BLIND METHOD;
|
|
EID: 0031602909
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/ajp.155.1.152 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|